The FDA is updating our October 28, 2019 safety communication on the use of AFX endovascular grafts with Duraply material (AFX with Duraply or AFX2).

http://www.fda.gov/medical-devices/safety-communications/update-fda-reminds-patients-and-health-care-providers-importance-least-yearly-lifelong-follow-use